Skip to main content
Erschienen in: International Journal of Colorectal Disease 1/2019

29.10.2018 | Original Article

The contribution of endoscopy quality measures to the development of interval colorectal cancers in the screening population: a systematic review

verfasst von: Deirdre M. Nally, Athena Wright Ballester, Gintare Valentelyte, Dara O. Kavanagh

Erschienen in: International Journal of Colorectal Disease | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Colon cancer is the second most common cause of cancer-related death and an important cause of morbidity. The natural history of carcinogenesis, via the adenoma-carcinoma sequence, permits screening, which reduces the relative risk of mortality by up to 16%. The efficacy of a screening programme is limited by the growth of interval colorectal cancers between screening examinations. Quantifying the rate of interval cancers and delineating contributing endoscopic factors are crucial to maximise the benefit of a screening program.

Methods

A systematic review was performed in accordance with PRISMA principles. Electronic databases were interrogated with a considered search strategy, and reference lists of retrieved papers were surveyed. For inclusion, studies included the rate of interval cancer (stated or calculated) and reported at least one of a predefined list of endoscopy characteristics. The primary outcome was to establish the rate of interval cancers. The secondary outcome was to determine the association between endoscopy quality measures and interval cancers.

Results

The search yielded 2067 papers. Seventy-six full text papers were reviewed. Fifteen papers met the inclusion criteria. In total, there were 117,793 colon cancers, 7281 of which were interval lesions, giving an overall rate of 6.2%. The adenoma detection rate (ADR) of the endoscopist performing the index operation was the most consistent endoscopy factor associated with development of interval cancers. The impact of setting, volume and bowel preparation varied between papers.

Conclusion

Interval cancers reduce the efficacy of colorectal screening programmes. Ensuring the quality of the endoscopy process, specifically by increasing the ADR of practitioners, is crucial to the reduction of the rate of interval cancers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ito E, Yoshida M, Suzuki N, Imakita T, Tsutsui N, Ohdaira H, Kitajima M, Suzuki Y (2018) Prophylactic retention suture for surgical site infection: a retrospective cohort study. J Surg Res 221:58–63CrossRefPubMed Ito E, Yoshida M, Suzuki N, Imakita T, Tsutsui N, Ohdaira H, Kitajima M, Suzuki Y (2018) Prophylactic retention suture for surgical site infection: a retrospective cohort study. J Surg Res 221:58–63CrossRefPubMed
2.
Zurück zum Zitat Hewitson P, Glasziou P, Irwig L, Towler B, Watson E (2007) Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev (1):Cd001216 Hewitson P, Glasziou P, Irwig L, Towler B, Watson E (2007) Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev (1):Cd001216
3.
Zurück zum Zitat Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366(8):687–696CrossRefPubMedPubMedCentral Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366(8):687–696CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Hewitson P, Glasziou P, Watson E, Towler B, Irwig L (2008) Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103(6):1541–1549CrossRefPubMed Hewitson P, Glasziou P, Watson E, Towler B, Irwig L (2008) Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103(6):1541–1549CrossRefPubMed
5.
Zurück zum Zitat Sanduleanu S, le Clercq CM, Dekker E, Meijer GA, Rabeneck L, Rutter MD et al (2015) Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut 64(8):1257–1267CrossRefPubMed Sanduleanu S, le Clercq CM, Dekker E, Meijer GA, Rabeneck L, Rutter MD et al (2015) Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut 64(8):1257–1267CrossRefPubMed
6.
Zurück zum Zitat Singh S, Singh PP, Murad MH, Singh H, Samadder NJ (2014) Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol 109(9):1375–1389CrossRefPubMed Singh S, Singh PP, Murad MH, Singh H, Samadder NJ (2014) Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol 109(9):1375–1389CrossRefPubMed
7.
Zurück zum Zitat Adler J, Robertson DJ (2015) Interval colorectal Cancer after colonoscopy: exploring explanations and solutions. Am J Gastroenterol 110(12):1657–1664 quiz 65 CrossRefPubMed Adler J, Robertson DJ (2015) Interval colorectal Cancer after colonoscopy: exploring explanations and solutions. Am J Gastroenterol 110(12):1657–1664 quiz 65 CrossRefPubMed
8.
Zurück zum Zitat van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E (2006) Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101(2):343–350CrossRefPubMed van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E (2006) Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101(2):343–350CrossRefPubMed
9.
Zurück zum Zitat Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG (1997) Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112(1):24–28CrossRefPubMed Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG (1997) Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112(1):24–28CrossRefPubMed
10.
Zurück zum Zitat Pohl H, Srivastava A, Bensen SP, Anderson P, Rothstein RI, Gordon SR et al (2013) Incomplete Polyp Resection During Colonoscopy—Results of the Complete Adenoma Resection (CARE) Study. Gastroenterology 144(1):74–80.e1CrossRefPubMed Pohl H, Srivastava A, Bensen SP, Anderson P, Rothstein RI, Gordon SR et al (2013) Incomplete Polyp Resection During Colonoscopy—Results of the Complete Adenoma Resection (CARE) Study. Gastroenterology 144(1):74–80.e1CrossRefPubMed
11.
Zurück zum Zitat Govindarajan A, Rabeneck L, Yun L, Tinmouth J, Paszat LF, Baxter NN (2016) Population-based assessment of the outcomes in patients with postcolonoscopy colorectal cancers. Gut 65(6):971–976CrossRefPubMed Govindarajan A, Rabeneck L, Yun L, Tinmouth J, Paszat LF, Baxter NN (2016) Population-based assessment of the outcomes in patients with postcolonoscopy colorectal cancers. Gut 65(6):971–976CrossRefPubMed
12.
Zurück zum Zitat Rees CJ, Thomas Gibson S, Rutter MD, Baragwanath P, Pullan R, Feeney M, Haslam N (2016) UK key performance indicators and quality assurance standards for colonoscopy. Gut 65(12):1923–1929CrossRefPubMedPubMedCentral Rees CJ, Thomas Gibson S, Rutter MD, Baragwanath P, Pullan R, Feeney M, Haslam N (2016) UK key performance indicators and quality assurance standards for colonoscopy. Gut 65(12):1923–1929CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ (2017) Colorectal Cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal Cancer. Gastroenterology 153(1):307–323CrossRefPubMed Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ (2017) Colorectal Cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal Cancer. Gastroenterology 153(1):307–323CrossRefPubMed
14.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefPubMed Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefPubMed
16.
Zurück zum Zitat Tsai CE, Wu KL, Chiu YC, Chuah SK, Tai WC, Hu ML, et al. (2018) The incidence and clinical associated factors of interval colorectal cancers in Southern Taiwan. J Formos Med Assoc 117(3):185–90CrossRefPubMed Tsai CE, Wu KL, Chiu YC, Chuah SK, Tai WC, Hu ML, et al. (2018) The incidence and clinical associated factors of interval colorectal cancers in Southern Taiwan. J Formos Med Assoc 117(3):185–90CrossRefPubMed
17.
Zurück zum Zitat Gotfried J, Bernstein M, Ehrlich AC, Friedenberg FK (2015) Administrative database research overestimates the rate of interval Colon Cancer. J Clin Gastroenterol 49(6):483–490PubMedPubMedCentral Gotfried J, Bernstein M, Ehrlich AC, Friedenberg FK (2015) Administrative database research overestimates the rate of interval Colon Cancer. J Clin Gastroenterol 49(6):483–490PubMedPubMedCentral
18.
Zurück zum Zitat Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP (2014) Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370(14):1298–1306CrossRefPubMedPubMedCentral Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP (2014) Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370(14):1298–1306CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L (2007) Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 132(1):96–102CrossRefPubMed Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L (2007) Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 132(1):96–102CrossRefPubMed
20.
Zurück zum Zitat Singh H, Nugent Z, Demers AA, Bernstein CN (2010) Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol 105(12):2588–2596CrossRefPubMed Singh H, Nugent Z, Demers AA, Bernstein CN (2010) Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol 105(12):2588–2596CrossRefPubMed
21.
Zurück zum Zitat Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM (2012) Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer 118(12):3044–3052CrossRefPubMed Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM (2012) Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer 118(12):3044–3052CrossRefPubMed
22.
Zurück zum Zitat Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L (2011) Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 140(1):65–72CrossRefPubMed Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L (2011) Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 140(1):65–72CrossRefPubMed
23.
Zurück zum Zitat Haseman JH, Lemmel GT, Rahmani EY, Rex DK (1997) Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc 45(6):451–455CrossRefPubMed Haseman JH, Lemmel GT, Rahmani EY, Rex DK (1997) Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc 45(6):451–455CrossRefPubMed
24.
Zurück zum Zitat Samadder NJ, Curtin K, Tuohy TM, Pappas L, Boucher K, Provenzale D et al (2014) Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology 146(4):950–960CrossRefPubMed Samadder NJ, Curtin K, Tuohy TM, Pappas L, Boucher K, Provenzale D et al (2014) Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology 146(4):950–960CrossRefPubMed
25.
Zurück zum Zitat Farrar WD, Sawhney MS, Nelson DB, Lederle FA, Bond JH (2006) Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 4(10):1259–1264CrossRefPubMed Farrar WD, Sawhney MS, Nelson DB, Lederle FA, Bond JH (2006) Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 4(10):1259–1264CrossRefPubMed
26.
Zurück zum Zitat Nayor J, Saltzman JR, Campbell EJ, Perencevich ML, Jajoo K, Richter JM (2017) Impact of physician compliance with colonoscopy surveillance guidelines on interval colorectal cancer. Gastrointest Endosc 85(6):1263–1270CrossRefPubMed Nayor J, Saltzman JR, Campbell EJ, Perencevich ML, Jajoo K, Richter JM (2017) Impact of physician compliance with colonoscopy surveillance guidelines on interval colorectal cancer. Gastrointest Endosc 85(6):1263–1270CrossRefPubMed
27.
Zurück zum Zitat Richter JM, Campbell EJ, Chung DC (2015) Interval colorectal cancer after colonoscopy. Clin Colorectal Cancer 14(1):46–51CrossRefPubMed Richter JM, Campbell EJ, Chung DC (2015) Interval colorectal cancer after colonoscopy. Clin Colorectal Cancer 14(1):46–51CrossRefPubMed
28.
Zurück zum Zitat le Clercq CM, Bouwens MW, Rondagh EJ, Bakker CM, Keulen ET, de Ridder RJ et al (2014) Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut 63(6):957–963CrossRefPubMed le Clercq CM, Bouwens MW, Rondagh EJ, Bakker CM, Keulen ET, de Ridder RJ et al (2014) Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut 63(6):957–963CrossRefPubMed
29.
Zurück zum Zitat Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Nowacki MP, Butruk E (2010) Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362(19):1795–1803CrossRefPubMed Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Nowacki MP, Butruk E (2010) Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362(19):1795–1803CrossRefPubMed
30.
Zurück zum Zitat Shergill AK, Conners EE, McQuaid KR, Epstein S, Ryan JC, Shah JN et al (2015) Protective association of colonoscopy against proximal and distal colon cancer and patterns in interval cancer. Gastrointest Endosc 82(3):529–37.e1CrossRefPubMedPubMedCentral Shergill AK, Conners EE, McQuaid KR, Epstein S, Ryan JC, Shah JN et al (2015) Protective association of colonoscopy against proximal and distal colon cancer and patterns in interval cancer. Gastrointest Endosc 82(3):529–37.e1CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Duarte RB, Bernardo WM, Sakai CM, Silva GL, Guedes HG, Kuga R et al (2018) Computed tomography colonography versus colonoscopy for the diagnosis of colorectal cancer: a systematic review and meta-analysis. Ther Clin Risk Manag 14:349–360CrossRefPubMedPubMedCentral Duarte RB, Bernardo WM, Sakai CM, Silva GL, Guedes HG, Kuga R et al (2018) Computed tomography colonography versus colonoscopy for the diagnosis of colorectal cancer: a systematic review and meta-analysis. Ther Clin Risk Manag 14:349–360CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Garborg K, de Lange T, Bretthauer M (2017) Quality indicators in colonoscopy. Curr Treat Options Gastroenterol 15(3):416–428CrossRefPubMed Garborg K, de Lange T, Bretthauer M (2017) Quality indicators in colonoscopy. Curr Treat Options Gastroenterol 15(3):416–428CrossRefPubMed
33.
Zurück zum Zitat Morris EJA, Rutter MD, Finan PJ, Thomas JD, Valori R (2015) Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC in the English National Health Service. Gut 64(8):1248–1256CrossRefPubMed Morris EJA, Rutter MD, Finan PJ, Thomas JD, Valori R (2015) Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC in the English National Health Service. Gut 64(8):1248–1256CrossRefPubMed
34.
Zurück zum Zitat Chen SC, Rex DK (2007) Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol 102(4):856–861CrossRefPubMed Chen SC, Rex DK (2007) Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol 102(4):856–861CrossRefPubMed
35.
Zurück zum Zitat Kaminski MF, Wieszczy P, Rupinski M, Wojciechowska U, Didkowska J, Kraszewska E, Kobiela J, Franczyk R, Rupinska M, Kocot B, Chaber-Ciopinska A, Pachlewski J, Polkowski M, Regula J (2017) Increased rate of adenoma detection associates with reduced risk of colorectal Cancer and death. Gastroenterology 153(1):98–105CrossRefPubMed Kaminski MF, Wieszczy P, Rupinski M, Wojciechowska U, Didkowska J, Kraszewska E, Kobiela J, Franczyk R, Rupinska M, Kocot B, Chaber-Ciopinska A, Pachlewski J, Polkowski M, Regula J (2017) Increased rate of adenoma detection associates with reduced risk of colorectal Cancer and death. Gastroenterology 153(1):98–105CrossRefPubMed
36.
Zurück zum Zitat Wieszczy P, Regula J, Kaminski MF (2017) Adenoma detection rate and risk of colorectal cancer. Best Pract Res Clin Gastroenterol 31(4):441–446CrossRefPubMed Wieszczy P, Regula J, Kaminski MF (2017) Adenoma detection rate and risk of colorectal cancer. Best Pract Res Clin Gastroenterol 31(4):441–446CrossRefPubMed
37.
Zurück zum Zitat Denis B, Sauleau EA, Gendre I, Exbrayat C, Piette C, Dancourt V, Foll Y, Hadad HA, Bailly L, Perrin P (2014) The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study. Dig Liver Dis 46(2):176–181CrossRefPubMed Denis B, Sauleau EA, Gendre I, Exbrayat C, Piette C, Dancourt V, Foll Y, Hadad HA, Bailly L, Perrin P (2014) The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study. Dig Liver Dis 46(2):176–181CrossRefPubMed
38.
Zurück zum Zitat Williams JE, Holub JL, Faigel DO (2012) Polypectomy rate is a valid quality measure for colonoscopy: results from a national endoscopy database. Gastrointest Endosc 75(3):576–582CrossRefPubMed Williams JE, Holub JL, Faigel DO (2012) Polypectomy rate is a valid quality measure for colonoscopy: results from a national endoscopy database. Gastrointest Endosc 75(3):576–582CrossRefPubMed
39.
Zurück zum Zitat Fedewa SA, Flanders WD, Ward KC, Lin CC, Jemal A, Goding Sauer A, Doubeni CA, Goodman M (2017) Racial and ethnic disparities in interval colorectal Cancer incidence: a population-based cohort study. Ann Intern Med 166(12):857–866CrossRefPubMedPubMedCentral Fedewa SA, Flanders WD, Ward KC, Lin CC, Jemal A, Goding Sauer A, Doubeni CA, Goodman M (2017) Racial and ethnic disparities in interval colorectal Cancer incidence: a population-based cohort study. Ann Intern Med 166(12):857–866CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Sawhney MS, Farrar WD, Gudiseva S, Nelson DB, Lederle FA, Rector TS, Bond JH (2006) Microsatellite instability in interval Colon cancers. Gastroenterology 131(6):1700–1705CrossRefPubMed Sawhney MS, Farrar WD, Gudiseva S, Nelson DB, Lederle FA, Rector TS, Bond JH (2006) Microsatellite instability in interval Colon cancers. Gastroenterology 131(6):1700–1705CrossRefPubMed
41.
Zurück zum Zitat Parikh MP, Muthukuru S, Jobanputra Y, Naha K, Gupta NM, Wadhwa V et al (2017) Proximal sessile serrated adenomas are more prevalent in Caucasians, and gastroenterologists are better than nongastroenterologists at their detection. Gastroenterol Res Pract 2017:6710931CrossRefPubMedPubMedCentral Parikh MP, Muthukuru S, Jobanputra Y, Naha K, Gupta NM, Wadhwa V et al (2017) Proximal sessile serrated adenomas are more prevalent in Caucasians, and gastroenterologists are better than nongastroenterologists at their detection. Gastroenterol Res Pract 2017:6710931CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Shaukat A, Rector TS, Church TR, Lederle FA, Kim AS, Rank JM, Allen JI (2015) Longer withdrawal time is associated with a reduced incidence of interval Cancer after screening colonoscopy. Gastroenterology 149(4):952–957CrossRefPubMed Shaukat A, Rector TS, Church TR, Lederle FA, Kim AS, Rank JM, Allen JI (2015) Longer withdrawal time is associated with a reduced incidence of interval Cancer after screening colonoscopy. Gastroenterology 149(4):952–957CrossRefPubMed
43.
Zurück zum Zitat Rex DK (2017) Polyp detection at colonoscopy: Endoscopist and technical factors. Best Pract Res Clin Gastroenterol 31(4):425–433CrossRefPubMed Rex DK (2017) Polyp detection at colonoscopy: Endoscopist and technical factors. Best Pract Res Clin Gastroenterol 31(4):425–433CrossRefPubMed
44.
Zurück zum Zitat Rex DK (2000) Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc 51(1):33–36CrossRefPubMed Rex DK (2000) Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc 51(1):33–36CrossRefPubMed
45.
Zurück zum Zitat Arain MA, Sawhney M, Sheikh S, Anway R, Thyagarajan B, Bond JH, Shaukat A (2010) CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 105(5):1189–1195CrossRefPubMed Arain MA, Sawhney M, Sheikh S, Anway R, Thyagarajan B, Bond JH, Shaukat A (2010) CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 105(5):1189–1195CrossRefPubMed
46.
Zurück zum Zitat Shaukat A, Arain M, Anway R, Manaktala S, Pohlman L, Thyagarajan B (2012) Is KRAS mutation associated with interval colorectal cancers? Dig Dis Sci 57(4):913–917CrossRefPubMed Shaukat A, Arain M, Anway R, Manaktala S, Pohlman L, Thyagarajan B (2012) Is KRAS mutation associated with interval colorectal cancers? Dig Dis Sci 57(4):913–917CrossRefPubMed
Metadaten
Titel
The contribution of endoscopy quality measures to the development of interval colorectal cancers in the screening population: a systematic review
verfasst von
Deirdre M. Nally
Athena Wright Ballester
Gintare Valentelyte
Dara O. Kavanagh
Publikationsdatum
29.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 1/2019
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-018-3182-8

Weitere Artikel der Ausgabe 1/2019

International Journal of Colorectal Disease 1/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.